Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Session 2: Mutational discordance: the big challenge in personalized treatments - any solutions?
M Siddiqui1, M Chand2, C Eng3
1The Royal Marsden NHS Foundation Trust, Croydon University Hospital, Croydon, UK.
Abstract:
The great challenge for oncologists treating patients who are developing or progressing with metastatic disease is to be able to offer a truly personalized and targeted therapy that can have an early and meaningful effect on the course of the disease. At present the known molecular markers are limited in their frequency and reliability in determining the use of newer chemotherapies. Professor Eng discusses the challenges faced in ensuring timely and effective treatments based on the molecular profile of the tumour and the potential role of real-time analysis of mutational changes in the tumour when progression occurs.
Insights
Personalized cancer therapy faces challenges due to limited molecular markers. Real-time analysis of tumor mutations could enable timely, effective treatments for metastatic disease.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Metastatic cancer treatment requires personalized, targeted therapies for optimal outcomes.
- Current molecular markers are insufficient for reliably guiding newer chemotherapy choices.
Purpose of the Study:
- To discuss challenges in delivering timely, molecularly-guided cancer treatments.
- To explore the potential of real-time tumor mutation analysis during disease progression.
Main Methods:
- Review of current challenges in personalized oncology.
- Discussion of molecular profiling and its limitations.
- Exploration of real-time mutational analysis concepts.
Main Results:
- Limited frequency and reliability of current molecular markers hinder personalized therapy.
- Timely and effective treatment decisions are challenged by current diagnostic methods.
Conclusions:
- Personalized cancer treatment necessitates improved molecular markers.
- Real-time analysis of tumor mutational changes offers a promising avenue for adaptive therapy during progression.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Solution Concentration and Dilution
Osmosis and Osmotic Pressure of Solutions

